Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Patients with PD Having Lumbar Surgery: Greater LOS

Parkinsons Dis; ePub 2018 Jun 27; Steinberger, et al

Parkinson disease (PD) patients undergoing lumbar surgery for degenerative conditions have increased length of stay (LOS) and costs when compared to patients without PD, according to a recent study. Researchers examined the Nationwide Inpatient Sample from 2002 to 2011. Patients were included for study based on ICD-9-CM procedural codes for lumbar spine surgery and substratified to degenerative diagnoses. Incidence and baseline patient characteristics were determined. Multivariable analysis was performed to determine independent risk factors increasing incidence of lumbar fusion revision in PD patients. They found:

  • PD patients account for 0.9% of all degenerative lumbar procedures.
  • At baseline, PD patients are older (70.7 vs 58.9) and more likely to be male (58.6% male).
  • Mean LOS was increased in PD patients undergoing lumbar fusion (5.1 days vs 4.0 days) and lumbar fusion revision (6.2 days vs 4.8 days).
  • Costs were 7.9% higher for lumbar fusion and 25.2% higher for lumbar fusion revision in PD patients.
  • Multivariable analysis indicates that osteoporosis, fluid/electrolyte disorders, blood loss anemia, and insurance status are significant independent predictors of lumbar fusion revision in patients with PD.

Steinberger J, Gilligan J, Skovrlj B, et al. The effect of Parkinson’s disease on patients undergoing lumbar spine surgery. [Published online ahead of print June 27, 2018]. Parkinsons Dis. doi:10.1155/2018/8428403.

This Week's Must Reads

Recurrent Stroke Risk Higher for Blacks than Whites, Neurology; ePub 2018 Oct 3; Albright, Huang, et al

Sleep Duration/Stroke Link Differs by Race and Sex, Neurology; ePub 2018 Oct 3; Petrov, Howard, et al

Intracerebral Hemorrhage Survivors’ Outcomes Studied, J Stroke Cerebrovasc Dis; ePub 2018 Sep 28; Griauzde, et al

Probable OSA Common in Refractory Epilepsy, Epilepsia; ePub 2018 Sep 24; McCarter, et al

FDA Approves Tiglutik for Treatment of ALS, ITF Pharma news release; 2018 Sep 6

Must Reads in Movement Disorders

Is RLS Associated with Premotor Symptoms of PD?, J Neurol Sci; ePub 2018 Sep 1; Iwaki, Hughes, et al

Cognition Function and Increased Risk for PD, PLoS One; ePub 2018 Aug 20; Chahine, et al

Comparison of Tests for Cognitive Deficits in PD, Mov Disord; ePub 2018 Sep 14; Hoogland, et al

Spiral Drawings in ET Measure Motor Learning, Cerebellum; ePub 2018 Sep 11; Kim, Luo, et al

Appendectomy and Risk of Parkinson Disease, Mov Disord; ePub 2018 Sep 14; Palacios, et al